CRISPR/Cas9 Knockout Cell Lines and Lysates
Feb 14 2019 Read 278 Times
Amsbio has established a comprehensive portfolio of knock-out cell lines and lysates generated with CRISPR/Cas9 technology.
Using CRISPR/Cas9 gene editing technology for the generation of knock-out cell lines and cell lysates ensures the development of useful tools to validate antibody specificity and elucidate gene function. Knock-out cell lines and cell lysates are widely agreed to be the best negative controls to quickly and confidently prove an antibody’s specificity for a target of interest and ensure reproducibility.
Generated in the most widely used HEK293T, HeLa, and A549 cell lines, Amsbio gene edited homozygous knock-out cell lines work in the cells you know and trust. Consequently, you are no longer limited to highly specialised and altered backgrounds. Amsbio offers only 100% knock-out clonal lines meaning you don't have to work with pools of cells containing only a percentage of knockout cells.
Knock-out cell lysates from Amsbio are made from double knock-out cell lines and provide the perfect negative control for Western Blots to validate the specificity of antibodies or be used in functional assays. Each Amsbio knock-out cell lysate product comes with a cell-line matched wild type control.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Mass Spectrometry & Spectroscopy - 67th ASMS Conference on Mass Spectrometry and Allied Topics - Modular MS Bench System with Integrated Gas Supply for Sciex LC-MS/MS Unveile...
View all digital editions
Aug 04 2019 Anaheim, CA, USA
Aug 04 2019 Portland, OR, USA
Aug 05 2019 Lombard, IL, USA
Aug 25 2019 San Diego, CA, USA
Sep 01 2019 Berlin, Germany